
Parataxis Holdings LLC, a US-based investment firm, has announced a strategic investment of KRW 25 billion (~$18 million) to acquire control of Bridge Biotherapeutics, paving the way for the establishment of Parataxis Korea, the first publicly listed company in Korea with a Bitcoin (BTC) treasury strategy at its core.
💼 Changing Name, Changing Strategy: From Biotechnology to Digital Finance
According to the press release, after the deal is approved by shareholders, Bridge Bio will change its name to Parataxis Korea and officially become a native Bitcoin treasury firm, listed on KOSDAQ.
Edward Chin, founder of Parataxis Holdings, and
Andrew Kim, partner at Parataxis Capital,
will join the company’s new board of directors, with Kim taking on the role of CEO.
However, rather than completely transitioning into crypto, Parataxis Korea will retain its core biotech operations under the continued leadership of James Jungkue Lee, co-founder of Bridge Bio — and add a layer of BTC-focused financial strategy on top of its existing model.
📈 South Korea Becomes New Hub for “Bitcoin Business”
The deal marks Parataxis’ bold move to bring its Wall Street-style Bitcoin treasury strategy to Asia, following a wave of companies owning BTC such as:
Strategy (582,000 BTC) the world’s largest crypto treasury firm
Japan’s Metaplanet (10,000 BTC) a typical Asian success story
“Accumulating Bitcoin in corporate treasuries is a long-term strategy that not only brings value to shareholders but also strengthens the country’s economic position,” said Edward Chin. “With limited supply and the increasingly clear role of BTC as a global strategic asset, Parataxis Korea will create a new template for how businesses in Korea manage assets.”
🏦 BTC is becoming the new reserve asset for businesses
According to Standard Chartered, there are now 61 publicly listed companies outside the crypto industry that have started adopting BTC treasury strategies, double that of April. This is no longer an experimental trend but a real shift in financial structure.
These companies do not just see BTC as a speculative investment, but as an alternative reserve asset similar to gold in the previous era.
⚠️ Risks remain: Warnings from financial institutions
Not without warning: a report from Charles Schwab notes that overexposure to Bitcoin could expose businesses to liquidity risks, especially in the event of a sharp BTC correction.
Standard Chartered also estimates that if the price of BTC falls below $90,000, many companies could lose half of their treasury value. However, Parataxis said it will implement a disciplined and transparent allocation strategy, not “all-in” but combining active investment and capital preservation.
📌 Conclusion: A clear signal for a new era of finance in Asia
Parataxis Korea is not just an M&A deal but a big statement: Bitcoin is entering a phase of widespread recognition as a core part of corporate finance strategy, no longer confined to the crypto world.
As listed companies continue to shift a portion of their reserves to BTC, South Korea, one of Asia’s most developed financial markets, is becoming a new hot spot, and Parataxis Korea is the “leading bird”.